In PNAS this week: three-dimensional chromosome structure, ovarian cancer immunopeptidome, and more.
The initiative's four research projects will use use genetic and other technologies to detect and treat cancer at its earliest stages.
Among the winners are a number of investigators who will receive funding to support omics-focused research.
Stat News reports on how white supremacists cope with surprising genetic ancestry testing results.
Researchers saw partial overlap between variants influencing age-related methylation and neuronal patterns and those implicated in other traits or diseases.
In Science this week: a protective gene in C. elegans, and combining EHRs with genetic data to ID HLA-associated variants
The technology is based on the work of UCLA's Steve Horvath, who has shown that DNA methylation age could predict all-cause mortality later in life.
Applied Biocode intends to have panel for identifying 18 gastrointestinal pathogens on the clinical market by the end of the year.
The company is aiming to uncover the cause of fibromyalgia and to identify new disease-specific genetic biomarkers.
The University of California, Los Angeles-led team said the approach outperformed two established classification methods.
Researchers test gene therapy targeting a different cancer protein in a new trial, the New York Times reports.
Pennsylvania State University researchers found that salivary microRNAs could predict which kids would have longer concussion symptoms, according to NPR.
The Associated Press reports Alex Azar, the new Department of Health and Human Services secretary nominee, made millions of dollars as a pharmaceutical executive.
In PNAS this week: immune profiling of breast cancer, transposable element patterns in rice, and more.